Chapter/Section Purchase

1 Study Coverage
1.1 Pediatric Drugs and Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Mumps
1.2.8 Others
1.3 Market by Application
1.3.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pediatric Drugs and Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Pediatric Drugs and Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Pediatric Drugs and Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pediatric Drugs and Vaccines Sales by Region
2.4.1 Global Pediatric Drugs and Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Pediatric Drugs and Vaccines by Region (2023-2028)
2.5 Global Pediatric Drugs and Vaccines Revenue by Region
2.5.1 Global Pediatric Drugs and Vaccines Revenue by Region (2017-2022)
2.5.2 Global Pediatric Drugs and Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pediatric Drugs and Vaccines Sales by Manufacturers
3.1.1 Global Top Pediatric Drugs and Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pediatric Drugs and Vaccines in 2021
3.2 Global Pediatric Drugs and Vaccines Revenue by Manufacturers
3.2.1 Global Pediatric Drugs and Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pediatric Drugs and Vaccines Revenue in 2021
3.3 Global Pediatric Drugs and Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pediatric Drugs and Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pediatric Drugs and Vaccines Sales by Type
4.1.1 Global Pediatric Drugs and Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Pediatric Drugs and Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Pediatric Drugs and Vaccines Revenue by Type
4.2.1 Global Pediatric Drugs and Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Pediatric Drugs and Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Pediatric Drugs and Vaccines Price by Type
4.3.1 Global Pediatric Drugs and Vaccines Price by Type (2017-2022)
4.3.2 Global Pediatric Drugs and Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pediatric Drugs and Vaccines Sales by Application
5.1.1 Global Pediatric Drugs and Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Pediatric Drugs and Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Pediatric Drugs and Vaccines Revenue by Application
5.2.1 Global Pediatric Drugs and Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Pediatric Drugs and Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Pediatric Drugs and Vaccines Price by Application
5.3.1 Global Pediatric Drugs and Vaccines Price by Application (2017-2022)
5.3.2 Global Pediatric Drugs and Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pediatric Drugs and Vaccines Market Size by Type
6.1.1 North America Pediatric Drugs and Vaccines Sales by Type (2017-2028)
6.1.2 North America Pediatric Drugs and Vaccines Revenue by Type (2017-2028)
6.2 North America Pediatric Drugs and Vaccines Market Size by Application
6.2.1 North America Pediatric Drugs and Vaccines Sales by Application (2017-2028)
6.2.2 North America Pediatric Drugs and Vaccines Revenue by Application (2017-2028)
6.3 North America Pediatric Drugs and Vaccines Market Size by Country
6.3.1 North America Pediatric Drugs and Vaccines Sales by Country (2017-2028)
6.3.2 North America Pediatric Drugs and Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pediatric Drugs and Vaccines Market Size by Type
7.1.1 Europe Pediatric Drugs and Vaccines Sales by Type (2017-2028)
7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Type (2017-2028)
7.2 Europe Pediatric Drugs and Vaccines Market Size by Application
7.2.1 Europe Pediatric Drugs and Vaccines Sales by Application (2017-2028)
7.2.2 Europe Pediatric Drugs and Vaccines Revenue by Application (2017-2028)
7.3 Europe Pediatric Drugs and Vaccines Market Size by Country
7.3.1 Europe Pediatric Drugs and Vaccines Sales by Country (2017-2028)
7.3.2 Europe Pediatric Drugs and Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pediatric Drugs and Vaccines Market Size by Type
8.1.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Pediatric Drugs and Vaccines Market Size by Application
8.2.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Pediatric Drugs and Vaccines Market Size by Region
8.3.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pediatric Drugs and Vaccines Market Size by Type
9.1.1 Latin America Pediatric Drugs and Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Pediatric Drugs and Vaccines Revenue by Type (2017-2028)
9.2 Latin America Pediatric Drugs and Vaccines Market Size by Application
9.2.1 Latin America Pediatric Drugs and Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Pediatric Drugs and Vaccines Revenue by Application (2017-2028)
9.3 Latin America Pediatric Drugs and Vaccines Market Size by Country
9.3.1 Latin America Pediatric Drugs and Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Pediatric Drugs and Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Type
10.1.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Application
10.2.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Country
10.3.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck & Co., Inc. (USA)
11.1.1 Merck & Co., Inc. (USA) Corporation Information
11.1.2 Merck & Co., Inc. (USA) Overview
11.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck & Co., Inc. (USA) Recent Developments
11.2 Abbott Laboratories (USA)
11.2.1 Abbott Laboratories (USA) Corporation Information
11.2.2 Abbott Laboratories (USA) Overview
11.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Laboratories (USA) Recent Developments
11.3 Amgen, Inc. (USA)
11.3.1 Amgen, Inc. (USA) Corporation Information
11.3.2 Amgen, Inc. (USA) Overview
11.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Amgen, Inc. (USA) Recent Developments
11.4 Eli Lilly and Company (USA)
11.4.1 Eli Lilly and Company (USA) Corporation Information
11.4.2 Eli Lilly and Company (USA) Overview
11.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly and Company (USA) Recent Developments
11.5 F. Hoffmann-La Roche Ltd (Switzerland)
11.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Overview
11.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments
11.6 Genentech, Inc. (USA)
11.6.1 Genentech, Inc. (USA) Corporation Information
11.6.2 Genentech, Inc. (USA) Overview
11.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Genentech, Inc. (USA) Recent Developments
11.7 GlaxoSmithKline plc. (UK)
11.7.1 GlaxoSmithKline plc. (UK) Corporation Information
11.7.2 GlaxoSmithKline plc. (UK) Overview
11.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GlaxoSmithKline plc. (UK) Recent Developments
11.8 Janssen Biologics B.V. (USA)
11.8.1 Janssen Biologics B.V. (USA) Corporation Information
11.8.2 Janssen Biologics B.V. (USA) Overview
11.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Janssen Biologics B.V. (USA) Recent Developments
11.9 Actelion Pharmaceuticals
11.9.1 Actelion Pharmaceuticals Corporation Information
11.9.2 Actelion Pharmaceuticals Overview
11.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Actelion Pharmaceuticals Recent Developments
11.10 AstraZeneca Plc. (UK)
11.10.1 AstraZeneca Plc. (UK) Corporation Information
11.10.2 AstraZeneca Plc. (UK) Overview
11.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AstraZeneca Plc. (UK) Recent Developments
11.11 Boehringer Ingelheim GmbH (Germany)
11.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
11.11.2 Boehringer Ingelheim GmbH (Germany) Overview
11.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Boehringer Ingelheim GmbH (Germany) Recent Developments
11.12 Bristol-Myers Squibb Company (USA)
11.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
11.12.2 Bristol-Myers Squibb Company (USA) Overview
11.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bristol-Myers Squibb Company (USA) Recent Developments
11.13 Allergan, Inc. (USA)
11.13.1 Allergan, Inc. (USA) Corporation Information
11.13.2 Allergan, Inc. (USA) Overview
11.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Allergan, Inc. (USA) Recent Developments
11.14 Novartis AG (Switzerland)
11.14.1 Novartis AG (Switzerland) Corporation Information
11.14.2 Novartis AG (Switzerland) Overview
11.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Novartis AG (Switzerland) Recent Developments
11.15 Novo Nordisk A/S (Denmark)
11.15.1 Novo Nordisk A/S (Denmark) Corporation Information
11.15.2 Novo Nordisk A/S (Denmark) Overview
11.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Novo Nordisk A/S (Denmark) Recent Developments
11.16 Pfizer, Inc. (USA)
11.16.1 Pfizer, Inc. (USA) Corporation Information
11.16.2 Pfizer, Inc. (USA) Overview
11.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Pfizer, Inc. (USA) Recent Developments
11.17 Sanofi S.A (France)
11.17.1 Sanofi S.A (France) Corporation Information
11.17.2 Sanofi S.A (France) Overview
11.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Sanofi S.A (France) Recent Developments
11.18 Shionogi Inc. (USA)
11.18.1 Shionogi Inc. (USA) Corporation Information
11.18.2 Shionogi Inc. (USA) Overview
11.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Shionogi Inc. (USA) Recent Developments
11.19 Takeda
11.19.1 Takeda Corporation Information
11.19.2 Takeda Overview
11.19.3 Takeda Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Takeda Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Takeda Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pediatric Drugs and Vaccines Industry Chain Analysis
12.2 Pediatric Drugs and Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pediatric Drugs and Vaccines Production Mode & Process
12.4 Pediatric Drugs and Vaccines Sales and Marketing
12.4.1 Pediatric Drugs and Vaccines Sales Channels
12.4.2 Pediatric Drugs and Vaccines Distributors
12.5 Pediatric Drugs and Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pediatric Drugs and Vaccines Industry Trends
13.2 Pediatric Drugs and Vaccines Market Drivers
13.3 Pediatric Drugs and Vaccines Market Challenges
13.4 Pediatric Drugs and Vaccines Market Restraints
14 Key Findings in The Global Pediatric Drugs and Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer